In the long human effort to bridge mind and machine, a Chinese medical technology company has reached a meaningful threshold. Weiling Medical, founded in 2019 at the crossroads of neuroscience and surgical device engineering, has secured more than 100 million yuan to carry implantable brain-computer interfaces from controlled research into the lived reality of clinical medicine. The capital, led by Junzhong Capital and joined by a constellation of established venture firms, reflects a broader maturation in how seriously the world is beginning to treat the possibility of restoring lost agency t
Weiling Medical Secures $14M+ for Implantable Brain-Computer Interface
Weiling Medical's implantable BCI systems aim to restore neurological function and improve quality of life for patients with severe brain injuries and neurological disorders.